BioLineRx Ltd.
(NASDAQ : BLRX)

( )
BLRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 8.39%47.650.0%$182.73m
HZNPHorizon Therapeutics Plc 3.53%102.045.4%$177.52m
VRXValeant Pharmaceuticals International, Inc. 3.49%25.1914.1%$148.22m
CTLTCatalent, Inc. 2.18%123.502.0%$130.63m
ICLRICON plc 4.76%278.592.8%$113.63m
CPIXCumberland Pharmaceuticals, Inc. -17.58%5.720.6%$81.06m
JAZZJazz Pharmaceuticals Plc 1.88%123.792.1%$79.06m
UTHRUnited Therapeutics Corp. 0.90%190.4113.9%$73.23m
PRGOPerrigo Co. Plc 0.97%37.406.9%$67.14m
BHCBausch Health Cos., Inc. 3.49%25.190.0%$61.53m
ARGXargenx SE 4.86%292.520.0%$59.83m
ENDPEndo International Plc 4.98%5.278.5%$34.16m
PCRXPacira Biosciences, Inc. 4.99%56.809.8%$26.44m
QLGNQualigen Therapeutics, Inc. 7.63%1.270.0%$26.25m
IRWDIronwood Pharmaceuticals, Inc. 2.23%11.449.5%$25.83m

Company Profile

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which focuses on oncology. Its oncology programs include Motaxafortide (BL-8040), which is therapy platform used in the treatment of pancreatic cancer; and AGI-134 is a immunotherapy treatment used fro multiple solid tumors. The company was founded in April 2003 and is headquartered in Modi'in, Israel.